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Background
Metabolic complications of HAART are well known. Yet
the structural effects are rarely described. We report the
baseline carotid artery intima-media thickness (IMT),
mesenteric and subcutaneous fat in a pilot study for
investigating their changes following treatment with
lipid lowering agents in the presence of HAART.
Methods
All subjects were stable HIV positive patients receiving
HAART. All have been attending a specialist clinic for
monitoring HIV-related metabolic complications.
Mesenteric, subcutaneous fat and IMT were measured
by ultrasound operated by a specialist ultrasonographer.
Fasting lipid was measured on the same day of ultra-
sound measurement. The relationships between vari-
ables were analyzed by non parametric test and
univariate analysis of variance (ANOVA) where
appropriate.
Results
A total of 27 patients were recruited in the period
b e t w e e nJ u n e2 0 0 8a n dJ u n e2 0 0 9 .T h e yh a v eb e e no n
HAART for at least 2 years. Majority was male, while.
NRTI+PI, NRTI+NNRTI, NRTI+NNRTI+PI were pre-
scribed in 16, 9 and 2 patients respectively. The triple
agent group was not included in subsequent analysis
because of the small sample size. About 1/5 of patients
were on anti-lipid agents. The mean cholesterol, trigly-
ceride, IMT, mesenteric and subcutaneous fat of the
NRTI+PI group were 5.4+1.1 mmol/l, 3.59+2.38 mmol/l,
0.069+0.018 mm, 0.58+0.21 cm and 1.24+0.82 cm
respectively. The values of NRTI+NNRTI group were
4.88+1.3 mmol/l, 3.21+2.35 mmol/l, 0.069+0.017 mm,
0.97+0.27 mm and 1.94+1.28 mm respectively. Only the
mesenteric fat showed significant difference between the
2 groups, p<0.01. There was no significant relationship
between lipid and IMT.
Discussion and conclusions
Metabolic complications are commonly seen in HIV
patients receiving HARRT. It is known that hyperlipide-
mia, increased IMT and mesenteric fat are related.
However, there are little data on the effects of HAART
per se on these parameters. Protease inhibitor is known
to affect lipid by a class effect. Our results showed that
patients receiving NRTI+NNRTI had a higher mesen-
teric fat than those on NRTI+PI. However, we failed to
show any relationship between other parameters prob-
ably due to small sample size. Larger study would be
needed to confirm our finding and whether mesenteric
fat is a more sensitive marker to reflect metabolic
derangement.
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